Antiplatelet therapy in the perioperative period

Acta Anaesthesiologica Belgica

Volumn 61, Issue 3, 2010, Pages 139-143

  Engelen, Stefan ^a   Sinnaeve, Peter ^b   Van Damme, Hendrik ^c   Verhamme, Peter ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; THROMBOXANE A2; TICLOPIDINE; DRUG DERIVATIVE; PIPERAZINE DERIVATIVE; THIOPHENE DERIVATIVE; DABIGATRAN; DIPYRIDAMOLE; FONDAPARINUX; HEPARIN; RIVAROXABAN; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ANESTHESIST; BLEEDING; CARDIOLOGIST; CARDIOVASCULAR RISK; CONFERENCE PAPER; DRUG HALF LIFE; DRUG MONITORING; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PROSTATE SURGERY; REBOUND; SURGEON; THROMBOCYTE AGGREGATION; THROMBOSIS; REVIEW; ARTERY THROMBOSIS; BLOOD TOXICITY; BRAIN ISCHEMIA; CORONARY ARTERY BYPASS GRAFT; DRUG METABOLISM; ENZYME INHIBITION; LOW DRUG DOSE; MORTALITY; RISK FACTOR; THROMBOCYTE TRANSFUSION; TREATMENT WITHDRAWAL; VENOUS THROMBOEMBOLISM;

ASPIRIN; HUMANS; PERIOPERATIVE PERIOD; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; THIOPHENES; TICLOPIDINE;

EID: 79952213907     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Davi G., Patrono C., Platelet activation and atherothrombosis, N. ENGL. J. MED., 357 (24) : 2482-94, 2007.
2. Baigent C., Blackwell L., Collins R., Emberson J., Godwin J., Peto R., et al., Aspirin in the primary and secondary prevention of vascular disease : collaborative meta-analysis of individual participant data from randomised trials, LANCET., 373 (9678), 1849-60, 2009.
3. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ., 324 (7329): 71-86, 2002.
4. Patrono C., Bachmann F., Baigent C., Bode C., De CR, Charbonnier B., et al., Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. EUR. HEART J., 25 (2), 166-81, 2004. (Pubitemid 38112156)
5. Douketis J. D., Berger P. B., Dunn A. S., Jaffer A. K., Spyropoulos A. C., Becker R. C., et al., The perioperative management of antithrombotic therapy : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), CHEST., 133 (6 Suppl), 299S-339S, 2008. (Pubitemid 351894915)
6. Spyropoulos A. C., Douketis J. D., Guidelines for antithrombotic therapy : periprocedural management of antithrombotic therapy and use of bridging anticoagulation. INT. ANGIOL., 27 (4), 333-43, 2008.
7. Merritt J. C., Bhatt D. L., The efficacy and safety of perioperative antiplatelet therapy., J. THROMB. THROMBOLYSIS, 17 (1), 21-7, 2004. (Pubitemid 39069458)
8. Topol E. J., Aspirin with bypass surgery-from taboo to new standard of care, N. ENGL. J. MED., 347 (17), 1359-60, 2002. (Pubitemid 35215328)
9. Krupski W. C., Update on perioperative evaluation and management of cardiac disease in vascular surgery patients, J. VASC. SURG., 36(6), 1292-308, 2002. (Pubitemid 36236360)
10. Clarke R. J., Mayo G., Price P., FitzGerald G. A., Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin, N. ENGL. J. MED., 325 (16), 1137-41, 1991.
11. Roth G. J., Majerus P. W., The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein, J. CLIN. INVEST., 56 (3), 624-32, 1975.
12. Vilahur G., Choi B. G., Zafar M. U., Viles-Gonzalez J. F., Vorchheimer D. A., Fuster V., et al., Normalization of platelet reactivity in clopidogrel-treated subjects. J. THROMB. HAEMOST., 5 (1), 82-90, 2007. (Pubitemid 44921071)
13. Patrono C., Baigent C., Hirsh J., Roth G., Antiplatelet drugs : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), CHEST, 133 (6 Suppl), 199S-233S, 2008. (Pubitemid 351894914)
14. Bhatt D. L., Bertrand M. E., Berger P. B., L'Allier P. L., Moussa I., Moses J. W., et al., Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting, J. AM. COLL. CARDIOL., 39 (1), 9-14, 2002. (Pubitemid 34059855)
15. Hochholzer W., Trenk D., Frundi D., Blanke P., Fischer B., Andris K., et al., Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention, CIRCULATION, 111 (20), 2560-4, 2005. (Pubitemid 40740853)
16. Patrono C., Garcia Rodriguez L. A., Landolfi R., Baigent C., Low-dose aspirin for the prevention of atherothrombosis, N. ENGL. J. MED., 353 (22), 2373-83, 2005. (Pubitemid 41713749)
17. Beving H., Zhao C., Albage A., Ivert T., Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment, BLOOD COAGUL FIBRINOLYSIS, 7 (1), 80-4, 1996. (Pubitemid 26106173)
18. Collet J. P., Montalescot G., Blanchet B., Tanguy M. L., Golmard J. L., Choussat R., et al., Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. CIRCULATION, 110 (16) : 2361-7, 2004. (Pubitemid 39407340)
19. Maulaz A. B., Bezerra D. C., Michel P., Bogousslavsky J., Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. ARCH NEUROL., 62 (8), 1217-20, 2005. (Pubitemid 41168347)
20. Ambrose J. A., Fuster V., The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses, HEART, 79 (1), 3-4, 1998. (Pubitemid 28179050)
21. Burger W., Chemnitius J. M., Kneissl G. D., Rucker G., Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis, J. INTERN. MED., 257 (5), 399-414, 2005. (Pubitemid 40604544)
22. Mangano D. T., Aspirin and mortality from coronary bypass surgery, N. ENGL. J. MED., 347 (17), 1309-17, 2002. (Pubitemid 35215321)
23. Schouten O., Bax J. J., Poldermans D. Management of patients with cardiac stents undergoing noncardiac surgery, CURR. OPIN. ANAESTHESIOL., 20 (3), 274-8, 2007. (Pubitemid 46701344)
24. Ferrari E., Benhamou M., Cerboni P., Marcel B., Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis, J. AM. COLL. CARDIOL., 45 (3), 456-9, 2005. (Pubitemid 40186800)
25. Vicenzi M. N., Meislitzer T., Heitzinger B., Halaj M., Fleisher L. A., Metzler H., Coronary artery stenting and non-cardiac surgery - a prospective outcome study. BR. J. ANAESTH. Jun ; 96 (6) : 686-93, 2006.
26. Vandermeulen E., Regional anaesthesia and anticoagulation, BEST. PRACT. RES. CLIN. ANAESTHESIOL., 24 (1), 121-31, 2010.
27. Gogarten W., Vandermeulen E., Van AH, Kozek S., Llau J. V., Samama C. M., Regional anaesthesia and anti-thrombotic agents : recommendations of the European Society of Anaesthesiology, EUR. J. ANAESTHESIOL., 2010.